DK0859000T3 - Isoxazol- og crotonsyreamidderivater og deres anvendelse som lægemidler og diagnostika - Google Patents
Isoxazol- og crotonsyreamidderivater og deres anvendelse som lægemidler og diagnostikaInfo
- Publication number
- DK0859000T3 DK0859000T3 DK98101030T DK98101030T DK0859000T3 DK 0859000 T3 DK0859000 T3 DK 0859000T3 DK 98101030 T DK98101030 T DK 98101030T DK 98101030 T DK98101030 T DK 98101030T DK 0859000 T3 DK0859000 T3 DK 0859000T3
- Authority
- DK
- Denmark
- Prior art keywords
- isoxazole
- diagnostics
- drugs
- acid derivatives
- crotonic acid
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
- C07C255/23—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same unsaturated acyclic carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19702988A DE19702988A1 (de) | 1997-01-28 | 1997-01-28 | Isoxazol- und Crotonsäureamidderivate und deren Verwendung als Arzneimittel und Diagnostika |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0859000T3 true DK0859000T3 (da) | 2003-05-12 |
Family
ID=7818547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98101030T DK0859000T3 (da) | 1997-01-28 | 1998-01-22 | Isoxazol- og crotonsyreamidderivater og deres anvendelse som lægemidler og diagnostika |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US5977151A (da) |
| EP (1) | EP0859000B1 (da) |
| JP (1) | JP4163776B2 (da) |
| KR (1) | KR100572808B1 (da) |
| CN (1) | CN1120160C (da) |
| AR (1) | AR010399A1 (da) |
| AT (1) | ATE231495T1 (da) |
| AU (1) | AU729750B2 (da) |
| BR (1) | BR9800501B1 (da) |
| CA (1) | CA2228060C (da) |
| CZ (1) | CZ296122B6 (da) |
| DE (2) | DE19702988A1 (da) |
| DK (1) | DK0859000T3 (da) |
| ES (1) | ES2189010T3 (da) |
| HK (1) | HK1009813A1 (da) |
| HU (1) | HUP9800147A3 (da) |
| PL (1) | PL194932B1 (da) |
| PT (1) | PT859000E (da) |
| RU (1) | RU2192421C2 (da) |
| TR (1) | TR199800117A3 (da) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355678B1 (en) * | 1998-06-29 | 2002-03-12 | Parker Hughes Institute | Inhibitors of the EGF-receptor tyrosine kinase and methods for their use |
| WO2003042193A1 (en) * | 2001-11-09 | 2003-05-22 | Geneva Pharmaceuticals, Inc. | Process for preparing 5-methylisoxazole-4-carboxylic-(4'-trifluoromethyl)-anilide |
| US6727272B1 (en) | 2002-07-15 | 2004-04-27 | Unitech Pharmaceuticals, Inc. | Leflunomide analogs for treating rheumatoid arthritis |
| US7632916B2 (en) | 2002-08-02 | 2009-12-15 | 3M Innovative Properties Company | Process to modify polymeric materials and resulting compositions |
| US7157283B2 (en) * | 2002-08-02 | 2007-01-02 | 3M Innovative Properties Company | Continuous process for the production of combinatorial libraries of modified materials |
| US7125902B2 (en) * | 2004-05-28 | 2006-10-24 | Unitech Pharmaceuticals, Inc. | Methods, compounds, and diagnostics for cancer treatment |
| JP2008526877A (ja) * | 2005-01-05 | 2008-07-24 | エージェンコート パーソナル ジェノミクス | 可逆的ヌクレオチドターミネーターおよびその使用 |
| ES2614931T3 (es) | 2006-08-04 | 2017-06-02 | Beth Israel Deaconess Medical Center | Inhibidores de la piruvato cinasa y métodos de tratamiento de enfermedad |
| US20080085912A1 (en) * | 2006-10-06 | 2008-04-10 | Unitech Pharmaceuticals, Inc. | Isoxazole derivatives and methods of treating diseases |
| US20100213060A1 (en) * | 2009-02-23 | 2010-08-26 | Bio-Rad Laboratories, Inc. | Aqueous transfer buffer |
| WO2010118063A2 (en) | 2009-04-06 | 2010-10-14 | Agios Pharmaceuticals, Inc. | Therapeutic compositions and related methods of use |
| ES2619557T3 (es) | 2009-05-04 | 2017-06-26 | Agios Pharmaceuticals, Inc. | Activadores de PKM2 para uso en el tratamiento del cáncer |
| DK2448581T3 (da) | 2009-06-29 | 2017-03-13 | Agios Pharmaceuticals Inc | Terapeutiske sammensætninger og fremgangsmåder til disses anvendelser |
| EP3241554B1 (en) | 2009-06-29 | 2020-01-29 | Agios Pharmaceuticals, Inc. | Quinoline-8-sulfonamide derivatives having an anticancer activity |
| US9221792B2 (en) | 2010-12-17 | 2015-12-29 | Agios Pharmaceuticals, Inc | N-(4-(azetidine-1-carbonyl) phenyl)-(hetero-) arylsulfonamide derivatives as pyruvate kinase M2 (PMK2) modulators |
| EP2655350B1 (en) | 2010-12-21 | 2016-03-09 | Agios Pharmaceuticals, Inc. | Bicyclic pkm2 activators |
| TWI549947B (zh) | 2010-12-29 | 2016-09-21 | 阿吉歐斯製藥公司 | 治療化合物及組成物 |
| WO2012151451A1 (en) | 2011-05-03 | 2012-11-08 | Agios Pharmaceuticals, Inc. | Pyruvate kinase activators for use in therapy |
| MA44392B1 (fr) | 2015-06-11 | 2023-10-31 | Agios Pharmaceuticals Inc | Procédés d'utilisation d'activateurs de la pyruvate kinase |
| WO2023244542A1 (en) * | 2022-06-13 | 2023-12-21 | Yeefan Med Inc | Methods for detecting b-isox precipitates or captured proteins as biofluid biomarkers |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2854439A1 (de) * | 1978-12-16 | 1980-07-03 | Hoechst Ag | Ein isoxazolderivat, verfahren zu seiner herstellung, diese verbindung enthaltende mittel und verwendung |
| DE3534440A1 (de) * | 1985-09-27 | 1987-04-02 | Hoechst Ag | Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes |
| US5268382A (en) * | 1985-09-27 | 1993-12-07 | Hoechst Aktiengesellschaft | Medicaments to combat autoimmune diseases, in particular systemic lupus erythematosus |
| GB8619432D0 (en) * | 1986-08-08 | 1986-09-17 | Lilly Industries Ltd | Pharmaceutical compounds |
| DE3935016A1 (de) * | 1989-10-20 | 1991-04-25 | Behringwerke Ag | Glycosyl-etoposid-prodrugs, verfahren zu ihrer herstellung und ihre anwendung in kombination mit funktionalisiertem tumorspezifischen enzym-konjugaten |
| DK0527736T3 (da) * | 1990-05-18 | 1997-10-20 | Hoechst Ag | Isoxazol-4-carboxylsyreamider og hydroxyalkyliden-cyanoacetamider, lægemidler indeholdende disse forbindelser og anvendelsen af disse lægemidler. |
| US5744664A (en) * | 1990-07-05 | 1998-04-28 | Hoechst Aktiengesellschaft | Cycloolefin copolymers (COCS) as substrate material for liquid-crystal displays |
| ES2079765T3 (es) * | 1991-10-23 | 1996-01-16 | Hoechst Ag | Derivados de amidas de acido n-fenil-2-ciano-3-hidroxicrotonico y su utilizacion como medicamento con propiedad inmunomoduladora. |
| GB9200275D0 (en) * | 1992-01-08 | 1992-02-26 | Roussel Lab Ltd | Chemical compounds |
| ATE154526T1 (de) * | 1992-04-16 | 1997-07-15 | Merck Patent Gmbh | Aktivierte trägermaterialien, ihre herstellung und verwendung |
| DK0607776T3 (da) * | 1993-01-08 | 1999-08-16 | Hoechst Ag | Anvendelse af leflunomid til inhibering af tumornekrosefaktor alfa |
| WO1994024095A1 (en) * | 1993-04-16 | 1994-10-27 | Abbott Laboratories | Immunosuppressive agents |
| US6024957A (en) * | 1993-06-02 | 2000-02-15 | Research Corporation Technologies, Inc. | Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
-
1997
- 1997-01-28 DE DE19702988A patent/DE19702988A1/de not_active Withdrawn
-
1998
- 1998-01-22 EP EP98101030A patent/EP0859000B1/de not_active Expired - Lifetime
- 1998-01-22 DK DK98101030T patent/DK0859000T3/da active
- 1998-01-22 AT AT98101030T patent/ATE231495T1/de active
- 1998-01-22 ES ES98101030T patent/ES2189010T3/es not_active Expired - Lifetime
- 1998-01-22 DE DE59806965T patent/DE59806965D1/de not_active Expired - Lifetime
- 1998-01-22 PT PT98101030T patent/PT859000E/pt unknown
- 1998-01-23 US US09/012,570 patent/US5977151A/en not_active Expired - Lifetime
- 1998-01-26 CN CN98103677A patent/CN1120160C/zh not_active Expired - Fee Related
- 1998-01-26 CA CA002228060A patent/CA2228060C/en not_active Expired - Fee Related
- 1998-01-26 AR ARP980100334A patent/AR010399A1/es active IP Right Grant
- 1998-01-26 RU RU98102023/04A patent/RU2192421C2/ru not_active IP Right Cessation
- 1998-01-26 KR KR1019980002288A patent/KR100572808B1/ko not_active IP Right Cessation
- 1998-01-26 TR TR1998/00117A patent/TR199800117A3/tr unknown
- 1998-01-27 CZ CZ0024998A patent/CZ296122B6/cs not_active IP Right Cessation
- 1998-01-27 AU AU52748/98A patent/AU729750B2/en not_active Ceased
- 1998-01-27 JP JP01392298A patent/JP4163776B2/ja not_active Expired - Fee Related
- 1998-01-28 PL PL324549A patent/PL194932B1/pl not_active IP Right Cessation
- 1998-01-28 HU HU9800147A patent/HUP9800147A3/hu unknown
- 1998-01-28 BR BRPI9800501-4A patent/BR9800501B1/pt not_active IP Right Cessation
- 1998-09-24 HK HK98110901A patent/HK1009813A1/xx not_active IP Right Cessation
-
1999
- 1999-04-22 US US09/296,254 patent/US6121479A/en not_active Expired - Lifetime
-
2000
- 2000-05-30 US US09/580,625 patent/US6265588B1/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0859000T3 (da) | Isoxazol- og crotonsyreamidderivater og deres anvendelse som lægemidler og diagnostika | |
| NO991815L (no) | Oksadiazoler, fremgangsmÕter for deres fremstilling og deres anvendelse som medikamenter | |
| NO993003D0 (no) | Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter | |
| DK0911340T3 (da) | Substituerede isoquinolin-3-carboxylsyreamider, deres fremstilling og deres anvendelse som lægemiddel | |
| IS5130A (is) | Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum | |
| IS5129A (is) | Arýlsúlfonýlamínó hýdroxamsýruafleiður, notkun þeirra, ásamt lyfjablöndum | |
| NO20002486D0 (no) | Sykliske aminderivater og deres anvendelse som legemidler | |
| NO20020811D0 (no) | Sulfonylkarboksamidderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler | |
| DK0966454T3 (da) | Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler | |
| DK1083171T3 (da) | Pyrazolinderivater, deres fremstilling og anvendelse som medikamenter | |
| NO993868D0 (no) | 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike | |
| NO20032438L (no) | Ortosubstituerte og metasubstituerte bisarylforbindelser, fremgangsmåte forfremstilling derav, deres anvendelse som et medikament samtfarmasöytiske preparater inneholdende forbindelsene | |
| NO20000294L (no) | Derivater av acylpiperazinylpyrimidiner, deres fremstilling og anvendelse som legemidler | |
| NO20011503L (no) | Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, deres fremstilling og anvendelse som anorektiske legemidler | |
| NO972881D0 (no) | Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling | |
| NO975513D0 (no) | 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel | |
| NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| NO985368L (no) | Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene | |
| NO994671D0 (no) | Aryl- eller heteroarylsulfonamid-substituerte hydroksamsyrederivater, fremgangsmaate til fremstillint derav og deres anvendelse som farmasöytika | |
| NO971811D0 (no) | Bicykliske tetrahydropyrazolopyridiner og deres anvendelse som legemidler | |
| NO962952D0 (no) | 1,2,4-oksadiazolderivater og deres anvendelse som parasitticider for dyr | |
| NO981522L (no) | Aminosyrederivater, deres fremstilling og anvendelse som endotelinantagonister | |
| NO20006646D0 (no) | Aminosyrederivater og legemidler inneholdende de samme som aktiv bestanddel | |
| NO20000066D0 (no) | 6-pyrrolidin-2-ylpyrindin-derivater, deres fremstilling og deres farmasoeytiske anvendelse | |
| NO20015617L (no) | Spiroimidazolderivater, deres fremstilling, deres anvendelse og farmasöytiske preparater som innbefatter slike derivater |